In clinical oncology, GATK is used to analyze patient tumor samples to identify actionable mutations. These mutations can inform treatment decisions, such as the use of targeted therapies or immunotherapies. The accurate analysis provided by GATK ensures that clinicians can make informed decisions based on the genetic profile of the tumor.
